Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection

Simon M. Helfgott, MD  |  Issue: May 2014  |  May 1, 2014

In the U.S., AS was viewed as a variant of RA on the basis of a shared finding of an elevated erythrocyte sedimentation rate and the occasionally damaged peripheral joint. European clinicians argued for the distinction of AS from RA, because of its contrasting disease demographics, such as male preponderance and an earlier age of onset. In addition, the absence of subcutaneous nodules and the lack of response to gold salt therapy favored a unique diagnostic distinction. Ultimately, the discovery of rheumatoid factor and its widespread clinical application confirmed the European opinion.2

Regardless of whether one was a lumper or a splitter, a popular treatment for refractory AS was radiation therapy. The rationale for its use was best summarized by one of its major British advocates:3

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

There is no need to stress the tremendous economic importance of satisfactory treatment of this disease attacking as it does young men and women yet to reach their prime. The response to comprehensive radiotherapy is most encouraging and at times even dramatic. Probably it is correct to state that the results prove more gratifying than in any of the benign conditions which the radiotherapist is called upon to treat.

Sadly, it took many years and countless cases of leukemia before radiation therapy was abandoned as a treatment for AS.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Great Wasteland

The spine is a great wasteland. After all, this sizable chunk of body real estate does not readily lend itself to a careful, critical exam. For many doctors, it fails to attain the prominence of the heart, with its complex array of murmurs, rubs, clicking sounds and palpable heaves. Palpation of the spine fails to excite the examiner the way an enlarged spleen or liver does.

Who really bothers to carefully examine the back? Last week, I had the opportunity to teach our medical students the finer points of the musculoskeletal exam. Although they were familiar with some common sense approaches to the examination of the knee or the shoulder, they were lost when we moved to the back. Yes, one can palpate the spine and marvel at its flexibility or lack thereof, but these observations often provide us with little relevant information. Is there any utility palpating the sacroiliac joints? After all, in patients with back pain, everything seems to hurt down there!

Although the students were intrigued when I pulled out my tape measure to perform the Schober’s test, they were dismayed to learn that its namesake, Paul Schober, served as a physician at a German prisoner of war camp during World War II. We ended the session by demonstrating the arcane exercise of measuring the distance between the occiput of a patient’s head and an adjacent wall. This is where Home Depot meets rheumatology. Is there a more esoteric test in medicine than the occiput-to-wall measurement?

Dawning of a New Era: HLA- B27

Our wonderful colleague, Muhammad Asim Khan, MD, professor of medicine at Case Western University in Cleveland, Ohio, embodies the best of rheumatology. A thoughtful, articulate clinician and a patient himself, he has written extensively on the topic of AS.4 Khan vividly recalls how the link was made between HLA-B27 and AS.5

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:Ankylosing Spondylitisanti-inflammatorygeriatricsPainpatient careResearchrheumatologistrheumatologyTreatment

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    May 20, 2022

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

    Biophoto Associates / Science Source

    A Stiff Man: A Case Study in Ankylosing Spondylitis

    July 12, 2017

    First Appearances I watched the old man, his back painfully bent, shuffle toward the scale. A blocky rigidity draped over him. His feet seemed stuck to the floor. His head hung heavily over his chest. Observing him from the end of the hallway, instead of a face, I saw only a mound of shaggy, matted…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences